MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 25221-25230 Newer>
The Motley Fool
August 6, 2007
Tom Taulli
High Times at Taleo The little-known on-demand software company is finally getting on investors' radar. mark for My Articles 51 similar articles
The Motley Fool
August 6, 2007
Brian Lawler
Don't Discount ViroPharma The exciting biopharma announces its second-quarter financial results. Considering that its lead drug is highly profitable and has two strong pipeline candidates in development, shares of ViroPharma don't look expensive. mark for My Articles 44 similar articles
The Motley Fool
August 6, 2007
Brian Lawler
Unhappy Delays for MannKind Two delays for the inhalable insulin developer cause the stock to drop. mark for My Articles 56 similar articles
The Motley Fool
August 6, 2007
Lawrence Rothman
Timberland's Uphill Battle Timberland hopes to change its footprint. While the third quarter is expected to remain weak, cost cutting should help offset top-line weakness in the fourth quarter. mark for My Articles 113 similar articles
The Motley Fool
August 6, 2007
Lawrence Rothman
Playtex Gets Charged Up Even after a buyout by Energizer, Playtex keeps turning in solid quarters. Investors, take note. mark for My Articles 22 similar articles
The Motley Fool
August 6, 2007
Tom Taulli
Sourcefire Being Reduced to Ashes? The security company's prospects remain murky. And with investors shell-shocked from recent stock price drops, it's not easy to make a bull case. mark for My Articles 18 similar articles
The Motley Fool
August 6, 2007
Dave Mock
Foolish Forecast: How Now, Sprint Nextel? The wireless services provider will call in to report second-quarter earnings shortly. Investors, here is what you can expect to see. mark for My Articles 482 similar articles
The Motley Fool
August 6, 2007
Brian Orelli
Congress' Delay May Hurt Drugmakers The reauthorization of the Prescription Drug User Fee Act is delayed. If you're an investor in drug companies, now might be a good time to call your representatives and senators. mark for My Articles 414 similar articles
The Motley Fool
August 6, 2007
Dave Mock
Foolish Forecast: A Steady Line for InterDigital? The wireless firm is set to deliver its second-quarter earnings shortly. Investors, here is what you can expect to see. mark for My Articles 59 similar articles
The Motley Fool
August 6, 2007
Rich Duprey
Foolish Forecast: SAM I Am Boston Beer will report second-quarter financial results shortly. Investors, here is what you can expect to see. mark for My Articles 293 similar articles
<Older 25221-25230 Newer>    Return to current articles.